Adalimumab and Non-Arteritic Anterior Ischaemic Optic Neuropathy: A Case Report.

Neuroophthalmology

Department of Ophthalmology and Visual Sciences, John A. Moran Eye Center, University of Utah Salt Lake City, Utah USA.

Published: September 2014

Sequential anterior ischaemic optic neuropathy was observed in a patient treated with a tumour necrosis factor α (TNF) inhibitor, adalimumab, for ankylosing spondylitis. He developed decreased visual acuity in the right eye after 17 months of treatment. Findings showed right optic disc oedema with haemorrhages and visual field defect. Adalimumab was discontinued and vision stabilised. After restarting adalimumab, he developed optic neuropathy in the left eye. Findings showed optic disc oedema, with haemorrhages and visual field changes in the left eye. Adalimumab may be associated with optic neuropathy; providers prescribing TNF inhibitors should be aware of optic neuropathy as a potential complication.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5122979PMC
http://dx.doi.org/10.3109/01658107.2014.925940DOI Listing

Publication Analysis

Top Keywords

optic neuropathy
20
anterior ischaemic
8
ischaemic optic
8
findings optic
8
optic disc
8
disc oedema
8
oedema haemorrhages
8
haemorrhages visual
8
visual field
8
left eye
8

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!